Geron Corp. (NASDAQ: GERN) is 7.11% higher on its value in year-to-date trading and has touched a low of $1.68 and a high of $3.73 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GERN stock was last observed hovering at around $2.00 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $2.26, the stock is 13.27% and 10.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 13.53 million and changing 13.00% at the moment leaves the stock -6.35% off its SMA200. GERN registered -18.71% loss for a year compared to 6-month loss of -5.04%. The firm has a 50-day simple moving average (SMA 50) of $4.13k and a 200-day simple moving average (SMA200) of -$5.57.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 22.83% gain in the last 1 month and extending the period to 3 months gives it a 15.90%, and is 15.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.79% over the week and 7.57% over the month.
Geron Corp. (GERN) has around 141 employees, a market worth around $1.23B and $0.24M in sales. Profit margin for the company is -77691.14%. Distance from 52-week low is 34.52% and -39.49% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.38%).
Geron Corp. quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $20k over the same period.The EPS is expected to shrink by 0.00% this year, but quarterly earnings will post 26,942.20% year-over-year. Quarterly sales are estimated to shrink -4.80% in year-over-year returns.
Geron Corp. (GERN) Top Institutional Holders
261 institutions hold shares in Geron Corp. (GERN), with institutional investors hold 73.08% of the company’s shares. The shares outstanding are 544.91M, and float is at 447.58M with Short Float at 9.74%. Institutions hold 73.00% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 35.98 million shares valued at $115.49 million. The investor’s holdings represent 6.87% of the GERN Shares outstanding. As of Jun 29, 2023, the second largest holder is RA Capital Management, L.P. with 31.54 million shares valued at $101.26 million to account for 6.03% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 26.68 million shares representing 5.10% and valued at over $85.65 million, while Deep Track Capital, Lp holds 4.62% of the shares totaling 24.17 million with a market value of $77.59 million.
Geron Corp. (GERN) Insider Activity
A total of 2 insider transactions have happened at Geron Corp. (GERN) in the last six months, with sales accounting for 0 and purchases happening 2 times. The most recent transaction is an insider purchase by O’Farrell Elizabeth G.,the company’sDirector. SEC filings show that O’Farrell Elizabeth G. bought 6,607 shares of the company’s common stock on Aug 24 at a price of $2.28 per share for a total of $15064.0. Following the purchase, the insider now owns 7407.0 shares.
Geron Corp. disclosed in a document filed with the SEC on Aug 24 that O’Farrell Elizabeth G. (Director) bought a total of 6,579 shares of the company’s common stock. The trade occurred on Aug 24 and was made at $2.28 per share for $15000.0. Following the transaction, the insider now directly holds 26220.0 shares of the GERN stock.
Still, SEC filings show that on May 11, LAWLIS V BRYAN (Director) disposed off 35,000 shares at an average price of $3.00 for $0.1 million. The insider now directly holds 0 shares of Geron Corp. (GERN).
Geron Corp. (GERN): Who are the competitors?
The company’s main competitors (and peers) include Bio-Techne Corp. (TECH) that is trading -4.93% down over the past 12 months. Incyte Corp. (INCY) that is -23.87% lower over the same period.
